News

Under the agreements, Noven has granted Procter & Gamble Pharmaceuticals (P&GP) an exclusive worldwide license to a testosterone patch for the treatment of hypoactive sexual desire disorder (HSDD)

Rosetta Genomics has access to the majority of known human and viral microRNAs. From this strong intellectual property position, the company has developed highly sensitive, proprietary technologies to

Mr Conn has served as a financial executive in high growth companies for over 20 years. Mr Conn has extensive experience with mergers and acquisitions and capital transactions.

The company plans to launch its product in the fourth quarter of calendar 2008. With this approval, Barr’s US generic injectable portfolio now totals eight products.

According to the company, True2go offers patients the convenience of anywhere, on-the-go testing to help them better manage their diabetes, while Trueresult offers patients advanced monitoring capabilities at

The shares of common stock sold to the investors represent a 10% interest in the company. The company has also announced the conversion to the company’s common stock

The first patient enrolled in the study was treated by Lyudmila Bazhenova, the trial’s principal investigator at the University of California, San Diego School of Medicine. The study

Arpida is seeking approval of intravenous iclaprim in the EU for the treatment of complicated skin and soft tissue infections (cSSTI). Iclaprim is a hospital antibiotic drug candidate

Hoya’s vision care division will acquire 100% of the shares in Dioptra CZ. While the existing management team will remain in place, Rainer Burkard, director of global business